DAVID GRANOVSKY

Posts Tagged ‘penny’

Ameritrade stalls trading of BIEL & ASFX

In BUSINESS OF STEM CELLS on August 27, 2009 at 8:59 am

Traders angered and confused after Ameritrade stalls trading of two healthcare OTC stocks

August 26, 2009

If your biotech penny stock lost momentum in the last 24 hours, your trading platform may have something to do with it.

Investors following two increasingly popular biomed stocks are reacting angrily after Ameritrade’s decision to halt trading of American Scientific Resources (PINK SHEETS:ASFX) and BioElectronics Corporation (OTC:BIEL). Both stocks had been increasing in both volume and price per share in recent days, but got flagged by the widely used securities brokerage service which resulted in customers finding themselves unable to purchase shares.

Some day traders who use the platform, found themselves locked out after trading out of their positions while taking advantage of some of the wild swings that these penny stocks experience. They were reportedly allowed to trade out of the shares, but not allowed to buy back in. Prices for both stocks experienced pull back as investors pushed the panic button amid the confusion.

via American Chronicle | Traders angered and confused after Ameritrade stalls trading of two healthcare OTC stocks (OTC:BIEL).

Cord Blood America Inc. (OTC:CBAI) Top Traded OTC

In BUSINESS OF STEM CELLS on August 26, 2009 at 6:02 pm

Cord Blood America Inc. (OTC:CBAI) Is The Top Traded OTC Stock

stemcells_money1HARD TO TREAT DISEASES (PINK:HTDS) and Universal Detection Technology (OTC:UNDT) Round Out Top Three Volume Gainers During Morning Trading Hours

Dallas, TX 8/13/2009 02:35 PM GMT (TransWorldNews)

Dallas, TX – Penny Stock Pick Alert is a penny stock newsletter that is pleased to alert investors of top stocks on the move.

Cord Blood America Inc. (OTC:CBAI) is up 3% to $0.0032 on huge volume of 4.50 million shares within first hour of trade. On August 11, 2009, Cord Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical cord blood stem cell preservation companies focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced that work has begun at its new, 17,000 square foot facility in Las Vegas for conversion into a state-of-the-art laboratory for the storage of stem cells and for research and development.

HARD TO TREAT DISEASES (PINK:HTDS) is also moving higher by 23% at $0.0163 on very unusual volume of 92 million shares . Yesterday August 12, 2009 Hard to Treat Diseases, Inc. (HTDS:PK), announced that Hard To Treat Diseases (HTDS.PK) Completes IP Ownership Filings With U.S. Patent and Trademark Office.

via Cord Blood America Inc. (OTC:CBAI) Is The Top Traded OTC.

Cord Blood America Retires $1.6 Million in Debt

In BUSINESS OF STEM CELLS on August 26, 2009 at 6:01 pm

Cord Blood America $1.6 Million in Debt Retired in Third Quarter 2009

SANTA MONICA, Calif., Aug 25, 2009 — Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it has retired $1.6 million in debt since July 2009. The Company previously announced it retired $5 million in debt in the first half of 2009.

stemcells_money1“We have said that one of the pillars of strength for Cord Blood America in 2009 was to significantly reduce debt and we certainly are fulfilling this obligation to our shareholders,” said Matthew Schissler, founder and CEO. The Company also announced on August 5, 2009, that it retired $2.53 million of long-term debt with the payoff of two notes with the Shelter Island Opportunity Fund.

“Retirement of debt is good for our balance sheet and makes CBAI a better investment for our shareholders,” said Mr. Schissler. “We are pleased with a strengthened balance sheet, having recently announced second quarter results showing a significant increase in working capital and cash on hand.” About Cord Blood America Cord Blood America (OTC Bulletin Board: CBAI | Quote | Chart | News | PowerRating) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at http://www.corcell.com. For investor information, visit http://www.cordblood-america.com.

via BEEY,CBAI,CYDE,MBCI,NYMH,UBRG Www.standoutstocks.com: Stocks That Standout For 8/25/2009 Are UBRG, NYMH, CBAI, MBCI, CYDE.

Golden Dragon Holdings, Inc. (OTC:GDHI) Is The Top Traded O

In BUSINESS OF STEM CELLS on August 26, 2009 at 2:33 pm

Golden Dragon Holdings, Inc. (OTC:GDHI) Is The Top Traded OTC Stock

HARD TO TREAT DISEASES (PINK:HTDS) and IJJ CORP (PINK:IJJP) Round Out Top Three Percentage Gainers

Dallas, TX 8/26/2009 05:02 PM GMT (TransWorldNews)

Dallas, TX – WePickPennyStocks.com is pleased to alert investors of stocks on the move.

stemcells_money1HARD TO TREAT DISEASES (PINK:HTDS) is trading up 4% at $0.0118 on huge volume of 31 million shares. On 24 August, Hard to Treat Diseases Slavica Bio Chem http://www.slavicabiochem.com Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats. One of the goals of this project is to examine the potential role of Ribavirin in promoting survival of the stem cells transplanted after brain injury.

Golden Dragon Holdings, Inc. (OTC:GDHI) is also moving higher 23% at $0.0011 on very unusual volume of 77 million shares .Today August 26, Golden Dragon Holdings, Inc. announces that it has entered into a distribution agreement with Vosges, Ltd. http://www.vosgeschocolate.com a world leader in luxury gourmet chocolate and chocolate confessionary products. Under this agreement GDHI will exclusively place Vosges products in selectively hand-pick 5 star hotels in China.

IJJ CORP (PINK:IJJP) is trading up 250% at $0.0490 on huge volume of 2.29 million shares. today, August 26, JJ Corp. announced that the Company has acquired V-Clouds, a dynamic European technology company, for 4 million shares of IJJ Corp. (IJJC) restricted shares valued at $.25 per share from Cloud Technologies (Pink Sheets: CLDZ). V-Clouds’ main focus is in the Email Management and Security Space. The V-Clouds solution is for small businesses and large enterprises, as well as service providers. Dave Lovatt and Owen Dukes will remain with V-Clouds, with Dave Lovatt remaining on the Board as its President.

via Golden Dragon Holdings, Inc. (OTC:GDHI) Is The Top Traded O.

SYMPOWERCO CORP (PINK:SYMW) Is The Top Traded OTC Stock

In BUSINESS OF STEM CELLS on August 25, 2009 at 9:49 pm

HARD TO TREAT DISEASES (PINK:HTDS) is trading up 5% at $0.0103 on huge volume of 87 million shares. Yesterday, 24 August, Hard to Treat Diseases (HTDS.PK) Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats. One of the goals of this project is to examine the potential role of Ribavirin in promoting survival of the stem cells transplanted after brain injury.

via SYMPOWERCO CORP (PINK:SYMW) Is The Top Traded OTC Stock.

SYMPOWERCO CORP (PINK:SYMW) Top Traded OTC Stock

In BUSINESS OF STEM CELLS on August 25, 2009 at 9:48 pm

SYMPOWERCO CORP (PINK:SYMW) is also moving higher 10% at $0.0012 on very unusual volume of 210 million shares . Yesterday, 24 August, SymPowerco Corporation (PINKSHEETS: SYMW) CEO John Davenport announced today that the company has entered discussions and has signed a Non-Disclosure Agreement with an alternative energy and power systems corporation for the purpose of determining the advisability of establishing a business relationship that may include an acquisition or joint venture. SymPowerco has also entered similar discussions with a second group that owns advanced power system technologies and intellectual properties that appear to offer market opportunities for SymPowerco.

via SYMPOWERCO CORP (PINK:SYMW) Is The Top Traded OTC Stock.

UNIVERSAL BIOENERGY INC

In BUSINESS OF STEM CELLS on August 25, 2009 at 9:46 pm

UNIVERSAL BIOENERGY INC (PINK:UBRG) is trading up 915% at $0.355 on huge volume of 5.24 million shares. Today, 25 August Universal Bioenergy Inc., a company focused on the development and production of alternative energy sources and green technologies, announced today that it has signed a multi-million dollar contract with Mississippi Investment Petroleum Company (MIPCO), a next generation biofuels energy producer and marketer.

via SYMPOWERCO CORP (PINK:SYMW) Is The Top Traded OTC Stock.

Follow

Get every new post delivered to your Inbox.

Join 2,963 other followers

%d bloggers like this: